Formula (Ddavp 01)
Ddavp Injection
Product Images NDC 55566-2200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ddavp (NDC 55566-2200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (10 mL Vial Carton)
DDAVP is an injection medication containing desmopressin acetate. Each milliliter of the medication includes 4 mg of desmopressin acetate, 5 mg of chlorobutanol, 9 mg of sodium chloride, and hydrochloric acid for pH adjustment. The medication is refrigerated and intended for intravenous and subcutaneous use only. The dosage instructions can be found on the package insert. This medication is manufactured by Ferring Pharmaceuticals in Parsippany, New Jersey.*
Principal Display Panel (Ten 1 mL Ampule Carton)
DDAVP Injection is a medication containing 4g desmopressin acetate, used for intravenous and subcutaneous use only. The medication is stored refrigerated between 2-8°C and comes in ten 1 mL ampules of preservative-free solution. The package includes directions and warnings for use, and the manufacturer is Ferring Pharmaceuticals.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
